Skip to content
Reducing GLP-1 Side Effects (GI, Energy, Blood Sugar Swings)

Reducing GLP-1 Side Effects (GI, Energy, Blood Sugar Swings)

GLP-1 medications work, but side effects can be a dealbreaker. Nausea, bloating, fatigue, and sugar crashes are common—but they don’t have to derail your progress.

 


 

Why Side Effects Happen on GLP-1 Therapy

If you’ve experienced GI discomfort or low energy on a GLP-1 like Ozempic®, Wegovy®, Saxenda®, Mounjaro®, or Zepbound®, you’re not alone.

Most side effects are tied to how these medications work:

  • Slowed gastric emptying → food stays in your stomach longer, leading to nausea or bloating

  • Changes in appetite and nutrient intake → less food means fewer essential nutrients

  • Altered glucose response → rapid drops in blood sugar can cause fatigue or energy swings

These effects are normal—but they’re not inevitable.

 


 

How to Minimize Side Effects and Stay on Track

GLP-1 therapy is about more than just the injection. Managing nutrition, metabolism, and digestion can make the difference between barely tolerating the medication and thriving on it.

This is where targeted support like SLM+ can help:

  • Supports healthy glucose metabolism to reduce blood sugar dips

  • Promotes smoother digestion to help reduce bloating and discomfort

  • Helps maintain steady energy levels during calorie restriction

  • Encourages metabolic stability so your body adapts more comfortably

 


 

Other Tips for Managing GLP-1 Side Effects

 

  1. Eat smaller, slower meals to reduce digestive discomfort

  2. Stay hydrated (especially with electrolytes if nausea affects fluid intake)

  3. Avoid heavy, high-fat meals early in treatment

  4. Use SLM+ daily to stabilize glucose and energy support

  5. Listen to your body — dosing adjustments may be necessary

 


 

The Bottom Line

GLP-1s can be life-changing for weight loss, but side effects often determine whether people stay the course. By supporting your body where the medication can’t, you can reduce discomfort, keep your energy up, and improve your long-term success.

That’s why SLM+ was designed to be the missing piece—helping patients tolerate GLP-1 therapy better and get the results they deserve.

 


 

👉 Support your GLP-1 journey.

Learn how SLM+ can help reduce common side effects:

Explore SLM+

Medical Disclaimer:

STAAR LABS is not a licensed pharmacy, medical provider, or drug manufacturer. The information provided is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. SLM+ is a dietary supplement and is not intended to replace prescription medications or medical advice. Patients should consult their licensed healthcare provider before making any changes to their medical treatment, diet, or supplement use.


Trademark Disclaimer:

Ozempic®, Wegovy®, and Saxenda® are registered trademarks of Novo Nordisk A/S.

Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company.

STAAR LABS is not affiliated with, sponsored by, or endorsed by Novo Nordisk A/S or Eli Lilly and Company. References to these products are for informational purposes only to describe commonly prescribed GLP-1 therapies.


Research & Innovation Disclosure:

STAAR LABS collaborates with clinics, pharmacies, and healthcare professionals to advance innovation in real-world metabolic health protocols. We welcome research partners committed to improving outcomes through evidence-based nutraceutical and pharmaceutical strategies.

Leave a comment

Your email address will not be published.

Other Blogs

Explore the STAAR LABS Blog for insights that elevate your well-being.

Collapsible content

Add a short description for this section

References
Disclaimers

Medical Disclaimer:

STAAR LABS is not a licensed pharmacy, medical provider, or drug manufacturer. The information provided is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. SLM+ is a dietary supplement and is not intended to replace prescription medications or medical advice. Patients should consult their licensed healthcare provider before making any changes to their medical treatment, diet, or supplement use.

Trademark Disclaimer:

Ozempic®, Wegovy®, and Saxenda® are registered trademarks of Novo Nordisk A/S.

Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company.

STAAR LABS is not affiliated with, sponsored by, or endorsed by Novo Nordisk A/S or Eli Lilly and Company. References to these products are for informational purposes only to describe commonly prescribed GLP-1 therapies.

Research & Innovation Disclosure:

STAAR LABS collaborates with clinics, pharmacies, and healthcare professionals to advance innovation in real-world metabolic health protocols. We welcome research partners committed to improving outcomes through evidence-based nutraceutical and pharmaceutical strategies.

Cart 0

Your cart is currently empty.

Start Shopping